Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$19.05 - $28.32 $365,112 - $542,781
-19,166 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $77,423 - $104,908
-4,090 Reduced 17.59%
19,166 $492,000
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $275,816 - $506,283
23,256 New
23,256 $424,000
Q3 2020

Nov 16, 2020

SELL
$6.53 - $8.6 $181,429 - $238,942
-27,784 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $114,192 - $188,375
27,784 New
27,784 $182,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $60,454 - $141,828
-19,192 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $96,151 - $156,606
19,192 New
19,192 $147,000
Q4 2018

Feb 14, 2019

SELL
$4.04 - $6.75 $112,958 - $188,730
-27,960 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$4.28 - $7.32 $119,668 - $204,667
27,960 New
27,960 $192,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.